Literature DB >> 12867236

Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study.

Chi Chiu Mok1, Chak Sing Lau, Raymond W S Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12867236     DOI： 10.1016/s0002-9343(03)00135-9

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  21 in total

Review 1.  Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.

Authors:  Deana Lazaro
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

2.  SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus.

Authors:  J G Hanly; M B Urowitz; D Jackson; S C Bae; C Gordon; D J Wallace; A Clarke; S Bernatsky; A Vasudevan; D Isenberg; A Rahman; J Sanchez-Guerrero; J Romero-Diaz; J T Merrill; P R Fortin; D D Gladman; I N Bruce; K Steinsson; M Khamashta; G S Alarcón; B Fessler; M Petri; S Manzi; O Nived; G Sturfelt; R Ramsey-Goldman; M A Dooley; C Aranow; R Van Vollenhoven; M Ramos-Casals; A Zoma; K Kalunian; V Farewell
Journal:  Ann Rheum Dis       Date:  2011-02-21       Impact factor: 19.103

Review 3.  Neuropsychiatric lupus: new mechanistic insights and future treatment directions.

Authors:  Noa Schwartz; Ariel D Stock; Chaim Putterman
Journal:  Nat Rev Rheumatol       Date:  2019-03       Impact factor: 20.543

Review 4.  Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.

Authors:  Mariana Postal; Lilian T L Costallat; Simone Appenzeller
Journal:  CNS Drugs       Date:  2011-09-01       Impact factor: 5.749

Review 5.  Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.

Authors:  Virginia Fernandes Moça Trevisani; Aldemar A Castro; João Ferreira Neves Neto; Alvaro N Atallah
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

6.  Psychosis in a young female - a diagnostic and therapeutic challenge.

Authors:  Sharmin Nizam; Andrew Gough
Journal:  JRSM Short Rep       Date:  2010-08-31

7.  Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus.

Authors:  J G Hanly; M B Urowitz; L Su; S C Bae; C Gordon; D J Wallace; A Clarke; S Bernatsky; D Isenberg; A Rahman; G S Alarcón; D D Gladman; P R Fortin; J Sanchez-Guerrero; J Romero-Diaz; J T Merrill; E Ginzler; I N Bruce; K Steinsson; M Khamashta; M Petri; S Manzi; M A Dooley; R Ramsey-Goldman; R Van Vollenhoven; O Nived; G Sturfelt; C Aranow; K Kalunian; M Ramos-Casals; A Zoma; J Douglas; K Thompson; V Farewell
Journal:  Ann Rheum Dis       Date:  2009-04-08       Impact factor: 19.103

Review 8.  Diagnosis and management of neuropsychiatric SLE.

Authors:  John G Hanly
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

Review 9.  Possible novel biomarkers of organ involvement in systemic lupus erythematosus.

Authors:  Dinglei Su; Rui Liu; Xia Li; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2014-03-06       Impact factor: 2.980

Review 10.  Pragmatic approaches to therapy for systemic lupus erythematosus.

Authors:  Wen Xiong; Robert G Lahita
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.